Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New insights into signaling during myelination in zebrafish.
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Receptos doses first patient in Phase 2 trial for RPC1063 in ulcerative colitis
Limit cycle oscillations in standing human posture.
Multiple Sclerosis and Pregnancy: Current Considerations.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results.
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Focal vibration in neurorehabilitation.
Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe
Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years.
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
Necrotizing skin lesion and radial nerve palsy in a patient treated with glatiramer acetate.
Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
New Drugs Online report for idebenone
Effect of IFN β-1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients.
Keystone Symposium: Advances in the Knowledge and Treatment of Autoimmunity
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.

Pages